Positions

Vice Chair for Research
Baylor College of Medicine
Professor of Psychiatry and Behavioral Sciences
Marjorie Bintliff Johnson and Raleigh White Johnson, Jr. Chair for Research in Psychiatry
Menninger Department of Psychiatry & Behavioral Sciences
Baylor College of Medicine
Houston, TX, US
Director
Mood and Anxiety Disorders Program
Baylor College of Medicine
Houston, Texas, United States
Staff Physician
Michael E. DeBakey VA Medical Center

Education

Fellowship at Columbia University College Of Physicians And Surgeons
Residency at New York State Psychiatric Institute
MD from Baylor College Of Medicine
AB from Dartmouth College

Certifications

Board Certified
American Board of Psychiatry and Neurology
State of Texas Medical License

Professional Interests

  • Psychopharmacology
  • Treatment-resistant depression and anxiety
  • Biomarker research

Professional Statement

My clinical expertise is in the psychopharmacological management of adult patients with difficult-to-treat depressive and anxiety disorders.

Selected Publications

Memberships

Society of Biological Psychiatry
Anxiety and Depression Association of America
American College of Neuropsychopharmacology
American Psychiatric Association
American Medical Association
American Society of Clinical Psychopharmacology

Funding

Ezogabine: Developing Neuronal KCNQ Channel Modulators for Mood Disorders - #H-40062
NIMH (National Institute of Mental Health)
Lanicemine: NMDA Receptor Modulation for Hyperarousal in PTSD, funded by NIMH
National Institute of Mental Health
Lanicemine: NMDA Receptor Modulation for Hyperarousal in PTSD
NIMH (National Institute of Mental Health)
ELEKT-D: Treatment Resistant Depression: ECT Versus Ketamine - #H-40701
Patient-Centered Outcomes Research Institute (PCORI)
Aug vs. Switch: Treatment Resistant Depression: Augmentation Versus Switch - #H-40432
Patient-Centered Outcomes Research Institute (PCORI)
VA-LLK: Ketamine for Treatment Resistant Late-Life Depression - #H-36574
Department of Veterans Affairs
AV101: Electrophysiological Biomarkers of Kynurenine Pathway Modulator AV-101 in Healthy Volunteers: Treating Suicidal Veterans - #H-41830
Michael E DeBakey VA Medical Center / VistaGen Therapeutics